Research Collaborations

The following entities and institutions are currently collaborating with or have historically collaborated with researchers at the Prechter Bipolar Research Program. 
If you or your team is interested in collaborating with us, please contact our research director and principal investigator, Melvin McInnis, M.D. 

University of Michigan collaborations:  

College of Engineering 

College of Pharmacy 

School of Kinesiology

School of Nursing

School of Public Health 

School of Social Work

Ford School of Public Policy

Frankel Cardiovascular Center

Department of Cell and Developmental Biology

Department of Human Genetics

Department of Mathematics

Department of Neurology

Department of Pharmacology

Department of Psychiatry

Department of Psychology


National and international collaborations:

Cornell University
Deakin University, Australia
Johns Hopkins University *
Penn State Hershey College of Medicine
Stanford School of Medicine
University of Balamand and Institute for Development, Research, Advocacy, and Applied Care (IDRAAC), Lebanon
Weizmann Institute of Science, Israel
Weill Cornell Medical College


Institutions of Higher Education that requested samples or data from the Heinz C. Prechter Bipolar Research Program:  

Indiana University
Institute for Systems Biology
University of Texas Health Science Center
Michigan State University
University of Chicago
University of Illinois, Urbana Champaign
University of Wisconsin


We are engaged in several national and international research projects in bipolar disorder. 

Click here to learn more about our international collaborations.


National Network of Depression Centers (NNDC) 

The NNDC’s mission is to develop and foster connections among members to use the power of our network, to advance scientific discovery, and to provide stigma free, evidence-based care to patients with depressive and bipolar illnesses. The NNDC envisions a global experience that is without stigma, where all patients with depressive and bipolar illnesses receive effective treatment, and access to improved quality of life.